Embracing a new future-ready pharmacovigilance ecosystem
Following her attendance at DIA Europe 2024, Humaira Qureshi, President of Qinecsa Solutions, spoke with PharmaPhorum about the transforming pharmacovigilance landscape, the potential barriers and how organizations can embrace a new future-ready pharmacovigilance ecosystem. “This offers an opportunity to embrace novel technologies, aligned with culture and processes, to demonstrate how pharmacovigilance (PV) can save time, […]
Join Qinecsa at the Insife Annual Convention 2024
We are thrilled to announce that Humaira Qureshi, President of Qinecsa, will be a keynote speaker at the upcoming Insife Annual Convention 2024. The event is scheduled to take place on the 26th of September at the Novartis Campus in Basel, Switzerland. This convention serves as a premier gathering for pharmacovigilance professionals to explore the […]
Qinecsa shares latest innovations with industry media before DIA Global Annual Meeting 2024
Ahead of exhibiting at the 2024 DIA Global Annual Meeting, Qinecsa spoke with industry leading journal Outsourcing Pharma about the company’s latest breakthrough in clinical research technology, how it addresses the current challenges in the industry, and the major trends that will shape the future of pharmaceuticals. Qinecsa discusses the vast volumes of data and […]
Webinar: Vigilance Medical Device Guidance Part 2 – Reporting Essentials and Obligations
Webinar: Vigilance Medical Device Guidance Part 2 “Post-marketing safety surveillance of medical devices and DDC products, EU and USA” Join us for Part 2 of our webinar series on post-marketing safety surveillance, where we dive deeper into the intricate world of medical devices and drug-device combination products. Building upon the foundation set in Part 1, […]
Join Qinecsa at DIA Global Annual Meeting 2024
Qinecsa is thrilled to announce exhibiting at the DIA Global Annual Meeting, happening from June 16th to 20th in San Diego, CA. Redefining Healthcare through Innovation and Collaboration DIA is the largest multidisciplinary event that brings together a global network of life sciences professionals. The meeting fosters meaningful innovation that will lead to the development […]
Qinecsa releases on-demand webinar on mastering Medical Device regulations
On April 17, 2024, Qinecsa launched its first webinar, offering a deep dive into medical device regulations. The on-demand session, “Mastering Medical Device Regulations (EU) 2017/745,” is designed for pharmacovigilance professionals aiming to excel in compliance and operational effectiveness. The 50-minute webinar offers a thorough analysis of the latest EU medical device regulatory landscape, providing […]
Webinar: Vigilance Medical Device Guidance Part 1 – Mastering Medical Device Regulations
Webinar: Vigilance Medical Device Guidance Part 1 “Mastering Medical Device Regulations (EU) 2017/745” In this webinar, you will find an in-depth presentation of medical device regulations, essential for pharmacovigilance professionals seeking mastery in compliance and operational excellence. Veronika will guide participants through key regulatory requirements, integration challenges, and actionable steps for building resilient processes to […]
PV Insights Network Benchmarking Report: The dynamics of drug safety in small pharma, biotech, and medical devices
Drug safety is critical to protect patients and consumers exposed to pharmaceutical development and commercialized drugs. Although the principal framework for Drug Safety and PV operation is similar for all small pharma, biotech, and medical device companies, organized collection and analysis of this segment’s PV profile and process is limited. Efficient and effective drug safety […]
Stanley Capital-backed portfolio company Qinecsa acquires Insife
Press Release Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions. 21st March 2024 — Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announce its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms. This acquisition is in alignment […]
PV Insights Network White Paper: Key challenges to address pharmacovigilance needs
Drug safety leaders speak There are thousands of small pharma and biotech companies around the world. Yet when it comes to drug safety, these organizations often struggle to source specialist support that addresses the unique challenges they face. From April to June 2023, we undertook a roundtable series ‘Drug safety in small pharma and biotech’ […]
